Star Health & Allied Insurance Company Ltd Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹5,341 Cr +17.1% YoYSee revenue, profit and what management said. You are viewing Q1 FY26.
SH

Star Health & Allied Insurance Company Ltd

Q1 FY26Insurance

Star Health & Allied Insurance Company Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹4,880Cr
+27.9% YoY
+19.6% QoQ
Net profit
₹438Cr
+37.3% YoY
+43700% QoQ
Margin
12%
+1 pp YoY
+12.2 pp QoQ
Price₹578
Market cap₹34.6K Cr
P/E41.0

The short version

Star Health targets Rs. 2,500 crores profit by FY2028 with a broad split of 20% from underwriting and 80% from investment returns. Guidance for FY2028 projects INR 2,500 crores PAT on IFRS basis with underwriting profit contributing ~20% and investment returns ~80%.

From Star Health & Allied Insurance Company Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Star Health targets Rs. 2,500 crores profit by FY2028 with a broad split of 20% from underwriting and 80% from investment returns.
  • A strategy shift includes moderating the Rs. 30,000 crores top-line growth guidance to adjust for changes in corporate business focus.
  • Strong retail focus with retail health GWP growing 18% in Q1-FY2026 and fresh retail premiums growing 25%.
  • Digital fresh business growing impressively at 73%, with plans to accelerate this through a dedicated digital SBU.
  • Multi-year policies now contribute around 30% of new business volume, supporting better persistency and revenue visibility for 3 years.
  • Preferred geographies growing 1.5x faster than the overall business, focusing on higher ROE areas.

2 more points from Star Health & Allied Insurance Company Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

Guidance for FY2028 projects INR 2,500 crores PAT on IFRS basis with underwriting profit contributing ~20%…

Locked: what Star Health & Allied Insurance Company Ltd said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

A few pointers related to investments and strategic focus can be inferred: - Continued investments in technology over the last 2-3 years have improved manpower efficiency and digital business growth. - Plan to create a dedicated digital Strategic Business Unit (SBU) to accelerate the digital business. - Focus on digital direct business expansion, which is growing rapidly at 73% year-on-year in fresh business.

2 more points from Star Health & Allied Insurance Company Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Insurance

Ranked on what management guided this quarter

Guidance-ranked
1Niva Bupa Health
Rev 2Mar 3
2Max Financial
Rev 3Mar 2
3
Rev 3Mar 3
4
Rev 3Mar 3
Sign up free to see 2 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Star Health & Allied Insurance Company Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Star Health & Allied Insurance Company Ltd said on order book & pipeline — free account, 30 seconds.

Star Health & Allied Insurance Company Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Star Health & Allied Insurance Company Ltd Q1 FY26 results — key figures

Star Health & Allied Insurance Company Ltd Q1 FY26 reported results vs Q1 FY25, ₹ crore
₹ CrQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue4,8803,816+27.9%4,081+19.6%
Operating profit (EBITDA)588425+38.4%-7—
Operating margin12%11%+1 pp-0.2%+12.2 pp
Profit before tax588426+38%-1—
Net profit (PAT)438319+37.3%1+43700%
EPS (₹)7.455.45+36.7%0.01+74400%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹5.3K Cr, net profit ₹265 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Insurance this season

  • Medi Assist Healthcare Services (Q1 FY26)

    Q1 FY'26 saw 19% YoY premium growth, driven by strong new corporate wins (+Rs. Key concall takeaways from Medi Assist Healthcare Services's Q1 FY26 earnings cal

  • Life Insurance (Q1 FY26)

    Individual non-par business is a key focus area, with growth seen in higher-margin products and increased non-par share to 30.34% of individual APE. Key…

  • General Insuranc (Q1 FY26)

    Investment income from interest and dividends runs at approximately INR1,850 crores quarterly, excluding capital gains. Key concall takeaways from General…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Star Health & Allied Insurance Company Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Star Health & Allied Insurance Company Ltd Q1 FY26 results?

Star Health targets Rs. 2,500 crores profit by FY2028 with a broad split of 20% from underwriting and 80% from investment returns. Guidance for FY2028 projects INR 2,500 crores PAT on IFRS basis with underwriting profit contributing ~20% and investment returns ~80%.

What is Star Health & Allied Insurance Company Ltd share price analysis?

Star Health & Allied Insurance Company Ltd currently shows a neutral. The stock trades at a P/E of 41.0 with a market cap of ₹34,614 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Star Health & Allied Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.